Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Busting the billion-dollar myth: how to slash the cost of drug development.

× No keyword cloud information.

16 in total

1. DockingApp: a user friendly interface for facilitated docking simulations with AutoDock Vina.

Authors: Elena Di Muzio; Daniele Toti; Fabio Polticelli
Journal: J Comput Aided Mol Des Date: 2017-01-06 Impact factor: 3.686

Review 2. Non-profit Drug Research and Development at a Crossroads.

Authors: Szymon Jarosławski; Mondher Toumi; Pascal Auquier; Claude Dussart
Journal: Pharm Res Date: 2018-02-07 Impact factor: 4.200

3. Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia.

Authors: Sofia Merajver; Sameer Phadke; Matthew Soellner
Journal: Trans Am Clin Climatol Assoc Date: 2017

Review 4. Novel lead compounds in pre-clinical development against African sleeping sickness.

Authors: Michael Berninger; Ines Schmidt; Alicia Ponte-Sucre; Ulrike Holzgrabe
Journal: Medchemcomm Date: 2017-07-31 Impact factor: 3.597

Review 5. Affordable orphan drugs: a role for not-for-profit organizations.

Authors: Elin H Davies; Emma Fulton; Daniel Brook; Dyfrig A Hughes
Journal: Br J Clin Pharmacol Date: 2017-02-08 Impact factor: 4.335

Review 6. Reflections on the Future of Pharmaceutical Public-Private Partnerships: From Input to Impact.

Authors: Remco L A de Vrueh; Daan J A Crommelin
Journal: Pharm Res Date: 2017-06-06 Impact factor: 4.200

Review 7. Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics.

Authors: J Javier Hernandez; Michael Pryszlak; Lindsay Smith; Connor Yanchus; Naheed Kurji; Vijay M Shahani; Steven V Molinski
Journal: Front Oncol Date: 2017-11-14 Impact factor: 6.244

Busting the billion-dollar myth: how to slash the cost of drug development.